Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Morita

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences|May 22, 2021
Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study)Takeshi Ogura, Takaaki Eguchi, Kazunari Nakahara, et al.
International Journal of Molecular Sciences|September 21, 2016
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C VirusRyuta Shigefuku, Hideaki Takahashi, Hiroyasu Nakano, et al.
JAMA Oncology|March 7, 2024
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung CancerYoko Tsukita, Takehiro Tozuka, Kohei Kushiro, et al.
Gastrointestinal Endoscopy|September 17, 2021
Efficacy and factors affecting procedure results of short-type single-balloon enteroscopy-assisted ERCP for altered anatomy: a multicenter cohort in JapanYuki Tanisaka, Shomei Ryozawa, Takao Itoi, et al.
Cancer Science|April 4, 2022
Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expressionYasuyuki Ikezawa, Hidenori Mizugaki, Ryo Morita, et al.
Cancer Medicine|March 31, 2023
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancerDaisuke Morinaga, Hajime Asahina, Shotaro Ito, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2024
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trialHirotoshi Iihara, Masamichi Iwai, Ryo Morita, et al.
Biosensors|December 24, 2025
An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample VolumeWarisara Sretapunya, Thitiya Buranachat, Montita Prasomthong, et al.
Scientific Reports|December 1, 2021
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)Gaku Yamamoto, Hajime Asahina, Osamu Honjo, et al.
Japanese Journal of Clinical Oncology|December 10, 2024
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001Kazunari Tateishi, Hidenori Mizugaki, Yasuyuki Ikezawa, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Hepato-Biliary-Pancreatic Sciences|May 22, 2021
Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study)Takeshi Ogura, Takaaki Eguchi, Kazunari Nakahara, et al.
International Journal of Molecular Sciences|September 21, 2016
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C VirusRyuta Shigefuku, Hideaki Takahashi, Hiroyasu Nakano, et al.
JAMA Oncology|March 7, 2024
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung CancerYoko Tsukita, Takehiro Tozuka, Kohei Kushiro, et al.
Gastrointestinal Endoscopy|September 17, 2021
Efficacy and factors affecting procedure results of short-type single-balloon enteroscopy-assisted ERCP for altered anatomy: a multicenter cohort in JapanYuki Tanisaka, Shomei Ryozawa, Takao Itoi, et al.
Cancer Science|April 4, 2022
Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expressionYasuyuki Ikezawa, Hidenori Mizugaki, Ryo Morita, et al.
Cancer Medicine|March 31, 2023
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancerDaisuke Morinaga, Hajime Asahina, Shotaro Ito, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2024
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trialHirotoshi Iihara, Masamichi Iwai, Ryo Morita, et al.
Biosensors|December 24, 2025
An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample VolumeWarisara Sretapunya, Thitiya Buranachat, Montita Prasomthong, et al.
Scientific Reports|December 1, 2021
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)Gaku Yamamoto, Hajime Asahina, Osamu Honjo, et al.
Japanese Journal of Clinical Oncology|December 10, 2024
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001Kazunari Tateishi, Hidenori Mizugaki, Yasuyuki Ikezawa, et al.
Pageof 10